| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |